Patent ID: 6100247
Filing Date: 2000-08-08
Classification: A61K

Abstract:
A method of treating a patient afflicted with or prone to developing diabetic neuropathy, said method comprising administering an effective amount of a compound of formula I: ##STR3## wherein: R.sub.1 is hydrogen, alkyl or ##STR4## R.sub.2 and R.sub.4 are each individually SO.sub.3.sup.- M.sup.+, PO.sub.3.sup.2- M.sub.2.sup.2+, or PO.sub.2 S.sup.2- M.sub.2.sup.2+ ;R.sub.3 and R.sub.5 are each individually hydrogen, hydroxy or sulfhydryl;m and n are individually 0, 1, 2, 3 or 4, with the proviso that if m or n is 0, then R.sub.3 is hydrogen; andM is hydrogen or an alkali metal ion; ora pharmaceutically acceptable salt thereof.